4D MOLECULAR THERAPEUT
7.6200
25-November-24 16:45:01
15 minutes delayed
Stocks
-0.1700
-2.18%
Today's range
7.5200 - 8.2300
ISIN
N/A
Source
NASDAQ
-
4DMT Announces Presentations at ARVO 2024 Annual Meeting
01 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
28 Mar 2024 08:00:00 By Nasdaq GlobeNewswire
-
4DMT to Participate in Upcoming Investor Conferences
04 Mar 2024 08:00:00 By Nasdaq GlobeNewswire
-
4DMT Reports Full Year 2023 Financial Results and Operational Highlights
29 Feb 2024 16:05:00 By Nasdaq GlobeNewswire
-
12 Feb 2024 08:00:00 By Nasdaq GlobeNewswire
-
4D Molecular Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
06 Feb 2024 23:27:14 By Nasdaq GlobeNewswire
-
4D Molecular Therapeutics Announces Proposed Public Offering of Common Stock
05 Feb 2024 16:05:00 By Nasdaq GlobeNewswire
-
03 Feb 2024 17:00:00 By Nasdaq GlobeNewswire
-
23 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
4DMT Highlights Recent Clinical Pipeline Progress, Near-Term Milestones and Organizational Updates
04 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
03 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
21 Dec 2023 08:00:00 By Nasdaq GlobeNewswire
-
4DMT to Participate in Upcoming Investor Conferences
15 Nov 2023 08:00:00 By Nasdaq GlobeNewswire
-
4DMT Reports Third Quarter 2023 Financial Results and Operational Highlights
09 Nov 2023 16:19:53 By Nasdaq GlobeNewswire
-
01 Nov 2023 16:00:00 By Nasdaq GlobeNewswire
-
30 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
25 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
23 Oct 2023 08:00:00 By Nasdaq GlobeNewswire